Allergy Therapeutics plc
AGY.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£39 | -£40 | -£43 | -£14 |
| Dep. & Amort. | £4 | £4 | £4 | £4 |
| Deferred Tax | £0 | £0 | -£1 | -£15 |
| Stock-Based Comp. | £1 | £0 | £0 | £0 |
| Change in WC | -£3 | -£1 | £8 | -£6 |
| Other Non-Cash | £9 | £5 | £0 | £16 |
| Operating Cash Flow | -£29 | -£32 | -£31 | -£14 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£3 | -£3 | -£5 | -£3 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | -£0 | -£0 |
| Inv. Sales/Matur. | £0 | £2 | £0 | £0 |
| Other Inv. Act. | £0 | £0 | £0 | £0 |
| Investing Cash Flow | -£3 | -£1 | -£5 | -£3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £35 | £33 | £25 | -£1 |
| Stock Issued | £0 | £2 | £6 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£3 | -£2 | -£2 | -£2 |
| Financing Cash Flow | £32 | £31 | £30 | -£3 |
| Forex Effect | -£0 | -£0 | £0 | £0 |
| Net Chg. in Cash | -£0 | -£2 | -£6 | -£20 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £13 | £15 | £21 | £40 |
| End Cash | £13 | £13 | £15 | £21 |
| Free Cash Flow | -£32 | -£36 | -£36 | -£17 |